Canadian researchers from the University of Lethbridge said that the study, conducted in April, showed that 13 cannabis varieties with high content of CBD (cannabidiol) can affect the way ACE2 that coronavirus uses to access the body. It is reported by the New York Post.
Let’s see what the science says. Makes some sense biologically. CBD seems to be the active agent. https://t.co/2WpHrjQVDS
— Dr Drew (@drdrew) May 21, 2020
“The main thing is that any cannabis that you choose in the shop work”, – said Olga CTV.
Scientists clarify that we are talking about plants with a high content of anti-inflammatory CBD but low in THC content.
The study, which has not been peer-reviewed, was conducted in cooperation with research companies Pathway Rx and Swysh Inc.
Researchers are looking for funding to continue their efforts to support research initiatives aimed at solving problems COVID-19.
“Although our most effective extracts require further large-scale validation, our study is critical for future analysis of the impact of medical cannabis on COVID-19, the study says. – Given the current severe and rapidly evolving epidemiological situation, it is necessary to consider all possible treatment options”.